Cardiac Toxicity of AAV9 Vector Upon Heart-Specific Expression of an Immunogenic Non-Self Transgene

被引:0
|
作者
Park, Andrew [1 ]
Urakami, Akane [1 ]
Alfaro, Alex [2 ]
Wu, Herren [1 ]
Ikeda, Yasuhiro [1 ]
机构
[1] AstraZeneca, ADPE, Gaithersburg, MD USA
[2] AstraZeneca, CPSS, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
91
引用
收藏
页码:47 / 47
页数:1
相关论文
共 21 条
  • [1] Improved heart specific gene transfer of AAV9 vectors with microRNA regulated transgene expression
    Geisler, Anja
    Jungmann, Andreas
    Vetter, Roland
    Muller, Oliver
    Fechner, Henry
    HUMAN GENE THERAPY, 2009, 20 (11) : 1381 - 1381
  • [2] Vector Biodistribution and Transgene Expression in the Heart Following Gene Transfer of AAVrh.10 vs. AAV9 Capsids
    Selvan, Nithya
    Nair, Anju
    Fargnoli, Anthony S.
    Zhang, Jing
    Wang, Jie
    Bradford, William H.
    Granados, Sonia Gutierrez
    Law, Kenneth M.
    Fenn, Tim
    McCormac, Paul
    Barth, Jay
    Sheikh, Farah
    Khanna, Richie
    MOLECULAR THERAPY, 2023, 31 (04) : 590 - 590
  • [3] microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors
    Geisler, A.
    Jungmann, A.
    Kurreck, J.
    Poller, W.
    Katus, H. A.
    Vetter, R.
    Fechner, H.
    Mueller, O. J.
    GENE THERAPY, 2011, 18 (02) : 199 - 209
  • [4] microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors
    A Geisler
    A Jungmann
    J Kurreck
    W Poller
    H A Katus
    R Vetter
    H Fechner
    O J Müller
    Gene Therapy, 2011, 18 : 199 - 209
  • [5] Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune Responses
    Ciesielska, Agnieszka
    Hadaczek, Piotr
    Mittermeyer, Gabriele
    Zhou, Shangzhen
    Wright, J. Fraser
    Bankiewicz, Krystof S.
    Forsayeth, John
    MOLECULAR THERAPY, 2013, 21 (01) : 158 - 166
  • [6] Immune Response Activation and Neurotoxicity after Intrathecal Infusion of AAV9 Vector Encoding a Non-Self Reporter Protein in the Non-Human Primate
    Samaranch, Lluis
    San Sebastian, Waldy
    Kells, Adrian P.
    Bringas, John
    Pivirotto, Phillip
    Forsayeth, John
    Bankiewicz, Krystof S.
    MOLECULAR THERAPY, 2013, 21 : S227 - S227
  • [7] Tailored Expression of a Transgene to Specific Cell Types in the Central Nervous System After Peripheral Injection of AAV9
    Hudry, Eloise
    Dashkoff, Jonathan
    Lerner, Paul
    Takeda, Shuko
    Truong, Nhi
    Maguire, Casey
    Hyman, Bradley T.
    MOLECULAR THERAPY, 2016, 24 : S244 - S244
  • [8] Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9
    Dashkoff, Jonathan
    Lerner, Eli P.
    Nhi Truong
    Klickstein, Jacob A.
    Fan, Zhanyun
    Mu, Dakai
    Maguire, Casey A.
    Hyman, Bradley T.
    Hudry, Eloise
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16081
  • [9] NEURON-SPECIFIC TRANSGENE EXPRESSION OF IMP2 MEDIATED BY SYNAPSIN PROMOTER-DRIVEN AAV9
    Park, Danielle
    Blizard, Sarah
    Austin, Scarlett
    Harman, Joshua
    Haraszti, Samantha
    Xu, Mei
    FASEB JOURNAL, 2017, 31
  • [10] AAV9, AAVrh.10, and AAVrh.74 Exhibit Different Cell Type Tropisms in the Heart Following Systemic Delivery and AAV9 Mediates Superior Cardiomyocyte Transgene Expression in Murine and Non-Human Primate Models
    Cheng, Ze
    Easter, Emilee
    Rollosson, Lindsey M.
    Xu, Emma
    Zhou, Huanyu
    Doerner, Karl
    Lin, JianMin
    Ivey, Kathryn N.
    Hoey, Timothy
    Lombardi, Laura M.
    MOLECULAR THERAPY, 2024, 32 (04) : 250 - 250